U.S. spot Bitcoin ETFs hit $471 million in inflows, six-week high

U.S. spot Bitcoin ETFs hit $471 million in inflows, six-week high - GNcrypto

U.S. spot Bitcoin ETFs logged $471.3 million in net inflows Monday (April 6), a six-week high, led by BlackRock IBIT at $181.9 million and Fidelity FBTC at $147.3 million.

U.S. spot Bitcoin ETFs took in $471.3 million in net inflows on April 6, 2026, the strongest single-day total in more than six weeks. BlackRock’s iShares Bitcoin Trust brought in $181.9 million and Fidelity’s Wise Origin Bitcoin Fund added $147.3 million. ARK 21Shares’ ARKB recorded $118.7 million, and products from Grayscale, Bitwise and VanEck also drew new money.

The flows were spread across six issuers and marked the largest daily intake since Feb. 25, when net inflows reached $506 million. The pickup followed $173.7 million in net outflows on April 1.

U.S. spot Bitcoin ETFs hit $471 million in inflows, six-week high - GNcrypto

Interest extended beyond Bitcoin. Spot Ether funds recorded $120.2 million in net inflows on Monday, the highest daily figure since mid-March.

Tensions between the United States and Iran have stretched into a second month, and shipping restrictions in the Strait of Hormuz have lasted for weeks, contributing to higher global oil prices. President Donald Trump set an April 7 deadline for Iran to reopen the waterway and warned of a “complete demolition” of Iran’s power plants and bridges if the demand is not met.

Spot Bitcoin ETFs give investors exposure to the cryptocurrency during regular market hours without requiring direct custody of the token.

The material on GNcrypto is intended solely for informational use and must not be regarded as financial advice. We make every effort to keep the content accurate and current, but we cannot warrant its precision, completeness, or reliability. GNcrypto does not take responsibility for any mistakes, omissions, or financial losses resulting from reliance on this information. Any actions you take based on this content are done at your own risk. Always conduct independent research and seek guidance from a qualified specialist. For further details, please review our Terms, Privacy Policy and Disclaimers.

Articles by this author